OR WAIT 15 SECS
In 1996, the term biobank was first used by researchers Steffen Loft and Henrik Enghusen Poulsen to describe t...
Bengaluru-based Healthium Medtech, a global medtech company with a growing portfolio across surgical, post-sur...
PrecisionRNA Biotech (Prerna), a healthcare startup from Hyderabad, has announced the launch of Cantel™,...
India's Pharma Reforms Target Global Credibility
The Indian government has introduced several measures to simplify drug approvals and support innovation. Key reforms include updating the New Drug and Clinical Trial Rules (2019) and using digital platforms to handle regulatory submissions, with the goal of improving transparency, reducing approval timelines, strengthening pharmacovigilance, and maintaining quality standards. What do these reforms entail, how is the industry responding, and what steps lie ahead to make India’s pharmaceutical sector globally competitive?
For Feedback, please email us at: communications@mmactiv.com
Sign up here to access BioSpectrum India Flip Book.
Sign up here to access BioSpectrum India Flip Book
